Weifang Dacheng Bioengineering Co., Ltd

Country/Region: China     State/Province: Shandong

Main Products: Tilmicosin

Company Introduction
Tilmicosin is a macrolide antibiotic developed for veterinary use. It is recommended for treatment and prevention of pneumonia in cattle, sheep and pigs, associated with Pasteurella haemolytica, P. Multocida, Actinobacillus pleuropneumoniae, mycoplasma species and other microorganisms found sensitive to this compound. It is an antibiotic medicine with great antibiotic effect and broad antibiotic spectrum. Not show resistance and cross-resistance with other antibiotic often used in clinic. Mainly used in the Pleuropneumonia and the infection caused by Pasteurellaceae, Pasteurella and mycoplasma.
Company Overview

Business Type: Exporter, Trader

Year Established: 2002

Employees: 201 - 300 People

Plant Area: 5,000-10,000 square meters

Contact Information

Fax: 86-0536-5327717

Business Information

Main Markets: South America 10% Africa 9% Eastern Asia 8% Domestic Market 9% North America 11% Eastern Europe 10% Southern Europe 8% Mid East 10% Northern Europe 10% Oceania 15%

Trade Capacity: FOB, CFR, Express Delivery

Contract Manufacturing: Design Service Offered,Buyer Label Offered

Nearest Port: weifang

Trade & Financial Information

Annual Revenue: Below US$1 Million

Total Revenue: Below US$1 Million

Export Revenue: US$50 Million - US$100 Million

Annual Output: US$1 Million - US$2.5 Million

Registered Capital: US$2.5 Million - US$5 Million

Export Percentage: 71% - 80%

Payment Modes: USD, EUR, HKD

Lead Time: 31 days

Import/Export Mode: Have Own Export License

Product Showcase
tilmicosin

CL-Link > Health & Medicines in China Health & Medicines in Shandong Medicines in China Medicines in Shandong Oseltamivir in China Oseltamivir in Shandong